These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36458331)

  • 61. Effects of oxytocin receptor antagonism on social function and corticosterone release after adolescent social instability in male rats.
    Hodges TE; Eltahir AM; Patel S; Bredewold R; Veenema AH; McCormick CM
    Horm Behav; 2019 Nov; 116():104579. PubMed ID: 31449812
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome.
    Bochukova EG; Lawler K; Croizier S; Keogh JM; Patel N; Strohbehn G; Lo KK; Humphrey J; Hokken-Koelega A; Damen L; Donze S; Bouret SG; Plagnol V; Farooqi IS
    Cell Rep; 2018 Mar; 22(13):3401-3408. PubMed ID: 29590610
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse.
    Gould BR; Zingg HH
    Neuroscience; 2003; 122(1):155-67. PubMed ID: 14596857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients.
    Tauber M; Mantoulan C; Copet P; Jauregui J; Demeer G; Diene G; Rogé B; Laurier V; Ehlinger V; Arnaud C; Molinas C; Thuilleaux D
    Orphanet J Rare Dis; 2011 Jun; 6():47. PubMed ID: 21702900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prader-Willi syndrome: Hormone therapies.
    Tauber M; Diene G
    Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report.
    Martin A; State M; Anderson GM; Kaye WM; Hanchett JM; McConaha CW; North WG; Leckman JF
    Biol Psychiatry; 1998 Dec; 44(12):1349-52. PubMed ID: 9861478
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial.
    Hollander E; Levine KG; Ferretti CJ; Freeman K; Doernberg E; Desilva N; Taylor BP
    J Psychiatr Res; 2021 May; 137():643-651. PubMed ID: 33190843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neuropeptide therapeutics to repress lateral septum neurons that disable sociability in an autism mouse model.
    Borie AM; Dromard Y; Chakraborty P; Fontanaud P; Andre EM; François A; Colson P; Muscatelli F; Guillon G; Desarménien MG; Jeanneteau F
    Cell Rep Med; 2024 Nov; 5(11):101781. PubMed ID: 39423809
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emerging role of astrocytes in oxytocin-mediated control of neural circuits and brain functions.
    Baudon A; Clauss Creusot E; Althammer F; Schaaf CP; Charlet A
    Prog Neurobiol; 2022 Oct; 217():102328. PubMed ID: 35870680
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Spectrum of the Prader-Willi-like Pheno- and Genotype: A Review of the Literature.
    Juriaans AF; Kerkhof GF; Hokken-Koelega ACS
    Endocr Rev; 2022 Jan; 43(1):1-18. PubMed ID: 34460908
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Animal models for Prader-Willi syndrome.
    Zahova S; Isles AR
    Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Magel2 truncation alters select behavioral and physiological outcomes in a rat model of Schaaf-Yang syndrome.
    Reznik DL; Yang MV; Albelda de la Haza P; Jain A; Spanjaard M; Theiss S; Schaaf CP; Malovannaya A; Strong TV; Veeraragavan S; Samaco RC
    Dis Model Mech; 2023 Feb; 16(2):. PubMed ID: 36637363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sleeve gastrectomy leads to weight loss in the Magel2 knockout mouse.
    Arble DM; Pressler JW; Sorrell J; Wevrick R; Sandoval DA
    Surg Obes Relat Dis; 2016 Dec; 12(10):1795-1802. PubMed ID: 27396546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT
    Garfield AS; Davies JR; Burke LK; Furby HV; Wilkinson LS; Heisler LK; Isles AR
    Mol Brain; 2016 Dec; 9(1):95. PubMed ID: 27931246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.
    Khor EC; Fanshawe B; Qi Y; Zolotukhin S; Kulkarni RN; Enriquez RF; Purtell L; Lee NJ; Wee NK; Croucher PI; Campbell L; Herzog H; Baldock PA
    PLoS One; 2016; 11(1):e0148155. PubMed ID: 26824232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
    Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
    Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of Prader-Willi Syndrome gene MAGEL2 in severe childhood-onset obesity.
    O'Neill MA; Farooqi IS; Wevrick R
    Obes Res; 2005 Oct; 13(10):1841-2. PubMed ID: 16286533
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain.
    Meddle SL; Bishop VR; Gkoumassi E; van Leeuwen FW; Douglas AJ
    Endocrinology; 2007 Oct; 148(10):5095-104. PubMed ID: 17628000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative cellular-resolution map of the oxytocin receptor in postnatally developing mouse brains.
    Newmaster KT; Nolan ZT; Chon U; Vanselow DJ; Weit AR; Tabbaa M; Hidema S; Nishimori K; Hammock EAD; Kim Y
    Nat Commun; 2020 Apr; 11(1):1885. PubMed ID: 32313029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.